Showing results (21-30 of 266) with videos related to
Sort By:
Pageof 27
Frontiers in Bioengineering and Biotechnology|May 5, 2023
3D dynamic cultures of HGSOC organoids to model innovative and standard therapiesEnrico Cavarzerani, Isabella Caligiuri, Michele Bartoletti, et al.Bioelectrochemistry (Amsterdam, Netherlands)|September 30, 2022
Molecularly imprinted electrochemical sensor for the ultrasensitive detection of cytochrome cDavide Campagnol, Najmeh Karimian, Dino Paladin, et al.Expert Opinion on Therapeutic Patents|October 21, 2017
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)Carlotta Granchi, Isabella Caligiuri, Filippo Minutolo, et al.Current Drug Targets|March 10, 2010
CDK inhibitors: from the bench to clinical trialsFlavio Rizzolio, Tiziano Tuccinardi, Isabella Caligiuri, et al.Molecules (Basel, Switzerland)|January 2, 2020
The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to NanomedicineSamer Bayda, Muhammad Adeel, Tiziano Tuccinardi, et al.Cancers|February 13, 2021
Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer ResearchFahriye Duzagac, Gloria Saorin, Lorenzo Memeo, et al.Nanomaterials (Basel, Switzerland)|February 11, 2023
PEG-Coated MnZn Ferrite Nanoparticles with Hierarchical Structure as MRI Contrast AgentSedigheh Cheraghali, Ghasem Dini, Isabella Caligiuri, et al.Plos One|February 8, 2013
The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancerChiara Lucchetti, Isabella Caligiuri, Giuseppe Toffoli, et al.International Journal of Molecular Sciences|September 14, 2024
Liposomal Formulations of Metallodrugs for Cancer TherapyEleonora Botter, Isabella Caligiuri, Flavio Rizzolio, et al.Seminars in Cancer Biology|March 5, 2023
The metabolic crosstalk between PIN1 and the tumour microenvironmentIsabella Caligiuri, Canzonieri Vincenzo, Tomochiro Asano, et al.Pageof 27